Citius Oncology Inc [NASDAQ: CTOR] gained 6.90% or 0.1 points to close at $1.55 with a heavy trading volume of 174623 shares.
It opened the trading session at $1.46, the shares rose to $1.5817 and dropped to $1.346, the range by which the price of stock traded the whole day. The daily chart for CTOR points out that the company has recorded 39.64% gains over the past six months.
If we look at the average trading volume of 1.49M shares, CTOR reached to a volume of 174623 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Citius Oncology Inc [CTOR]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CTOR shares is $3.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CTOR stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Maxim Group have made an estimate for Citius Oncology Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on November 27, 2024.
The Average True Range (ATR) for Citius Oncology Inc is set at 0.13 The Price to Book ratio for the last quarter was 3.11, with the Price to Cash per share for the same quarter was set at 0.00.
Trading performance analysis for CTOR stock
Citius Oncology Inc [CTOR] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 9.15. With this latest performance, CTOR shares gained by 70.33% in over the last four-week period, additionally plugging by 39.64% over the last 6 months – not to mention a drop of -86.14% in the past year of trading.
An analysis of Institutional ownership at Citius Oncology Inc [CTOR]
There are presently around $0.76%, or 15.38%% of CTOR stock, in the hands of institutional investors.
